Sibylla Biotech raised €23M in a Series A round in Oct 2022. The company is based in Verona, Italy. Investors in the round: 3B Future Health Fund, CDP Venture Capital, Claris Ventures and 6 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €23M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
